West Pharmaceutical Services (WST) stock
Last close $396.69 on 2026-11-19 (-1.81%) · Sector: Healthcare
West Pharmaceutical Services designs and makes packaging and delivery systems for medicines, such as stoppers, seals, and syringe and vial parts, working side by side with drug and healthcare companies from early design through to the patient. It earns money by selling these products to those healthcare partners, so its results tend to follow how much medicine they package and deliver.
The business looks strong right now: revenue in the latest quarter was about $0.87 billion and operating margin, which is the share of sales left after running costs, rose to 30.6%. Over the past year the stock returned 53.9% versus 9.7% for the S&P 500, a broad index of large US companies, so it beat the market. Shares trade at a high price compared with earnings, with a P/E ratio of 44.5, and insiders sold about $5.4 million of stock in the past 90 days. The stock has moved sharply after some earnings reports, rising 12.9% the day after April's release while falling after two others.
Key numbers
- Market cap: $28.1B
- Revenue (last 12 months): $3.39B
- Revenue growth: +12.3%
- Gross margin: 37.6%
- Operating margin: 23.3%
- P/E: 44.5
- P/S: 8.3
- Debt to equity: 0.07
- Current ratio: 2.84
Quality score
Overall 42/100 · growth 40 · profitability 48 · financial health 80 · value 0
Performance and risk
1-year return +53.9% vs S&P 500 +9.7% · volatility 31.5% (S&P 500 13.8%) · largest drop -18.8% · beta 0.64
Stock move the day after earnings
- 2026-02-12: -1.0%
- 2026-04-23: +12.9%
- 2026-07-23: -0.8%
- 2026-10-29: +3.2%
Insider trades (12 months)
Bought $0.0M · sold $6.5M
WST stock research · WST options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.